Where Clinical Data, Science & Evidence Transforms Women’s Health
Evidence, Data & Innovation
Dedicated to R&D and Clinical Trials providing evidence generation and innovation
This stage explores strategies to advance clinical trials, from enhancing recruitment and retention to incorporating real-world evidence and previously overlooked data layers that can enrich research outcomes. It also examines how emerging AI tools are transforming the research landscape. Discover how these innovations are helping to close the sex-specific data gap and accelerate breakthroughs in women's health.
Register NowFeatured Presentations
Designing Better Outcomes Through Sex Specific Data
Michael Annichine
CEO
Magee Women's Research Institute and Foundation
Magee Women's Research Institute and Foundation
Accelerating Safe and Inclusive Early Drug Research for Women While Balancing Innovation and Fetal Safety
Sherene Min
VP, Head of Global Clinical Development
ViiV Healthcare
ViiV Healthcare
Addressing Design Barriers: Paving The Way for Sex Specific Data Clarity
Julieta Jimenez
Executive Director, Program Management Clinical Operations, V&I
AstraZeneca
AstraZeneca
The Next Generation of Clinical Trials Shaping the Future of Research
Fiona Marshall
President, Biomedical Research
Novartis
Novartis
Who Should Attend
- Pharma & biotech professionals focused on pipeline strategy, scouting, and trial innovation
- Clinical trial leaders specialising in recruitment, endpoints, AI, and digital biomarkers
- Clinicians driving evidence-based care and research advancements
- Payers and insurers leveraging data and evidence to inform policy and reimbursement decisions
Key Topics
Focus: Clinical evidence generation, data integration, AI, digital health, and research innovation
- Sex-specific data and inclusive evidence generation in women's health
- AI, advanced analytics, and algorithms that reflect female biology
- Wearables, remote monitoring, and decentralized clinical research
- EHR integration, interoperability, and data standardization
- Regulatory science, study design, and clinically meaningful endpoints
- Real-world evidence and continuous outcomes monitoring
- Innovation pathways from research breakthrough to clinical adoption
We believe in equitable healthcare. That’s why attendance is free for any medical officers and leaders within hospitals and healthcare systems, pharma, biotech, corporate enterprises and government officials.
See Our Fertility & Reproductive Health Stage
